Files in this item
Impact of the Diabetes Canada guidelines dissemination Strategy on the prescription of vascular protective medications in Canada
Item metadata
dc.contributor.author | Sullivan, Francis | |
dc.date.accessioned | 2018-09-20T15:30:10Z | |
dc.date.available | 2018-09-20T15:30:10Z | |
dc.date.issued | 2017-11-11 | |
dc.identifier | 250652623 | |
dc.identifier | 9b12a37b-e301-420a-95bb-63a778c9d23e | |
dc.identifier.citation | Sullivan , F 2017 , ' Impact of the Diabetes Canada guidelines dissemination Strategy on the prescription of vascular protective medications in Canada ' , Diabetes Canada. Canadian Society of Endocrinology and Metabolism Professional Conference and Annual Meetings , Edmonton , Canada , 1/11/17 - 4/11/17 . | en |
dc.identifier.citation | conference | en |
dc.identifier.other | ORCID: /0000-0002-6623-4964/work/48516884 | |
dc.identifier.uri | https://hdl.handle.net/10023/16053 | |
dc.format.extent | 574119 | |
dc.language.iso | eng | |
dc.subject | RC Internal medicine | en |
dc.subject | RM Therapeutics. Pharmacology | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject.lcc | RC | en |
dc.subject.lcc | RM | en |
dc.title | Impact of the Diabetes Canada guidelines dissemination Strategy on the prescription of vascular protective medications in Canada | en |
dc.type | Conference poster | en |
dc.contributor.institution | University of St Andrews. School of Medicine | en |
dc.contributor.institution | University of St Andrews. Population and Behavioural Science Division | en |
dc.description.status | Non peer reviewed | en |
dc.date.embargoedUntil | 2017-11-11 |
This item appears in the following Collection(s)
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.